No abstract available
Keywords:
cancer drugs; financial burden; insurers; out‐of‐pocket costs; policy.
MeSH terms
-
Antineoplastic Agents* / economics
-
Antineoplastic Agents* / therapeutic use
-
Drug Costs*
-
Humans
-
Neoplasms / drug therapy
-
Neoplasms / economics
-
United States